PATENT CLAIM ANALYSIS

Application Number: 15745273
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "184100"]

Abstract:
The present invention relates to methods and pharmaceutical compositions of inducing immune tolerance by mucosal vaccination with Fc-coupled antigens. In particular, the present invention relates to a method for inducing tolerance to one antigen of interest in a subject in need thereof, comprising the mucosal administration to the subject of a therapeutically effective amount of a recombinant chimeric construct comprising a FcRn targeting moiety and an antigen-containing moiety.

Claim (Index 8):
The method of  claim 1  wherein the subject is predisposed or believed to be predisposed to developing, or has already developed or is developing an immune reaction against a grafted tissue or grafted hematopoietic cells or grafted blood cells.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.53191
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15039524', '14961938', '12932310', '15763566', '12043769']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7134556867394949
- 35 USC 102 Novelty (BERT): 0.5043902680368502
- Combined Prediction Score: 0.6925491448692305
- Mean Citation Score: 210.949178
- Max Citation Score: 231.70863
- Similarity Product: 150.0636919165671

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test